9/22/2022 9:01:47 AM
New Data Show Veracyte's Decipher Prostate Genomic Classifier May Improve Identification Of Aggressive Prostate Cancer
8/11/2022 4:13:38 PM
Veracyte Appoints Eliav Barr To Its Board Of Directors
6/20/2022 8:23:28 AM
Veracyte Says New Data Show Strong Performance Of Veracyte’s Afirma Genomic Sequencing Classifier
6/3/2022 8:37:09 AM
Veracyte Announces Publication Of Data Reinforcing Clinical
utility Of Decipher Prostate Genomic Classifier
2/14/2022 8:25:35 PM
Data Validate Utility Of Veracyte' Decipher Prostate Genomic Classifier To Help Guide Therapy For Prostate Cancer
11/24/2021 4:35:28 AM
Veracyte Says Swedish Medical Technologies Product Council Recommends Prosigna Breast Cancer Assay
10/26/2021 9:28:48 AM
VCYT: Data Shows Clinical Utility Of Decipher Prostate Genomic Classifier In Tailoring Treatment For Prostate Cancer
10/25/2021 10:41:52 AM
Veracyte:Decipher Prostate Classifier Can Help Physicians& Patients Make Critical Treatment Decisions In Prostate Cancer
10/14/2021 8:42:57 AM
Veracyte To Present New Data At ASTRO 2021 Further Validate Clinical Utility Of Decipher Prostate Genomic Classifier
10/13/2021 9:01:16 AM
Veracyte : Publication Shows Ability Of Decipher Bladder Test To
Identify Tumors Most Likely To Respond To Chemotherapy
10/6/2021 8:37:29 AM
Veracyte To Present Data; Shows Performance Of Genomic Diagnostic Tests In Lung Cancer &Interstitial Lung Disease
9/1/2021 8:38:59 AM
Veracyte Appoints Joshua Klopper As Medical Director Of Endocrinology
8/3/2021 8:11:06 AM
Veracyte Says Completes HalioDx Acquisition
7/8/2021 8:36:56 AM
Veracyte Names Rob Brainin EVP And Chief Business Officer And Bill Zondler SVP And Chief Information Officer
6/14/2021 8:56:23 AM
Veracyte Says New Data Demonstrating Prognostic Utility Of
Decipher Prostate Genomic Classifier
6/1/2021 7:10:41 AM
Veracyte Agrees To Acquire HalioDx
5/26/2021 9:34:36 AM
Veracyte: New Data Show Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions In Thyroid Cancer FNA Samples
5/25/2021 9:17:54 AM
Veracyte Announces New Data Reinforcing Prognostic Utility Of Decipher Prostate Genomic Classifier At ASCO 2021